Literature DB >> 11206968

A new gene trap construct enriching for insertion events near the 5' end of genes.

T Thomas1, A K Voss, K Chowdhury, P Gruss.   

Abstract

The gene trap approach is based on the integration of a gene trap vector into the genome. This can be done either by electroporation of a plasmid construct or by infection with a viral vector. Commonly used viral gene trap vectors have been shown to select for integrations near the 5' end of genes. To date, no plasmid vector with a similar tendency has been reported. In this paper we describe a new plasmid vector, pKC199beta geo. This vector contained a short splice acceptor fragment from the Hoxc9 gene, a full length lacZ gene, including an ATG, and a reduced activity, mutant neomycin phosphotransferase gene as a selectable marker. This vector enriched the population of trapped genes in our gene trap screen for insertion events in the 5' end of genes. In the two cases examined the beta-galactosidase activity pattern accurately reflected the endogenous promotor activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11206968     DOI: 10.1023/a:1026595111913

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  24 in total

1.  A STUDY OF THE UREA-PRODUCED SUBUNITS OF BETA-GALACTOSIDASE.

Authors:  D ZIPSER
Journal:  J Mol Biol       Date:  1963-08       Impact factor: 5.469

2.  Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development.

Authors:  E M Coccia; C Cicala; A Charlesworth; C Ciccarelli; G B Rossi; L Philipson; V Sorrentino
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

3.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice.

Authors:  G Friedrich; P Soriano
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

4.  Developmental regulation of the distribution of rat brain insulin-insensitive (Glut 1) glucose transporter.

Authors:  S Devaskar; D S Zahm; L Holtzclaw; K Chundu; B E Wadzinski
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

5.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.

Authors:  B P Zambrowicz; G A Friedrich; E C Buxton; S L Lilleberg; C Person; A T Sands
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

6.  Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence.

Authors:  M D Adams; A R Kerlavage; R D Fleischmann; R A Fuldner; C J Bult; N H Lee; E F Kirkness; K G Weinstock; J D Gocayne; O White
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

7.  A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure.

Authors:  R L Yenofsky; M Fine; J W Pellow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Molecular characterization of the murine argininosuccinate synthetase locus.

Authors:  L C Surh; A L Beaudet; W E O'Brien
Journal:  Gene       Date:  1991-03-15       Impact factor: 3.688

9.  Differential screening of a PCR-generated mouse embryo cDNA library: glucose transporters are differentially expressed in early postimplantation mouse embryos.

Authors:  D E Smith; T Gridley
Journal:  Development       Date:  1992-11       Impact factor: 6.868

10.  Structure and expression pattern of the murine Hox-3.2 gene.

Authors:  J R Erselius; M D Goulding; P Gruss
Journal:  Development       Date:  1990-10       Impact factor: 6.868

View more
  1 in total

1.  Splice variant of mouse Stam2 mRNA in nervous and muscle tissue contains additional exon with stop codon within region coding for VHS domain.

Authors:  Marija Curlin; Vedran Lucić; Srećko Gajović
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.